Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Comparative Effectiveness Could Take A Close Look At CAM - Sebelius

This article was originally published in The Tan Sheet

Executive Summary

Comparative effectiveness research required under health care reform likely will be used to carefully test the value of complementary and alternative medicines rather than simply hold up those products as less-expensive alternatives to pharmaceuticals

You may also be interested in...



Group recommends targeting CER for priority populations

Federal agencies should target comparative effectiveness research funds for studies involving racial and ethnic minorities, children, women, the elderly and people with multiple chronic conditions, the Brookings Institution's Engelberg Center for Health Care Reform says. The center's draft report recommends government organizations that support CER "allocate research funds to meritorious investigator-initiated proposals that are responsive to priority populations, and create targeted funding opportunities to fill gaps." The health care reform Congress enacted in March requires CER and gives oversight to a federal institute operating in a public/private partnership mode (1"The Tan Sheet" April 19, 2010). The draft notes research does not focus enough on conditions that affect priority populations, and priority populations typically are not recruited for trials. Another problem is the clinical trials infrastructure is not set up to allow for more participation from members of priority groups

Group recommends targeting CER for priority populations

Federal agencies should target comparative effectiveness research funds for studies involving racial and ethnic minorities, children, women, the elderly and people with multiple chronic conditions, the Brookings Institution's Engelberg Center for Health Care Reform says. The center's draft report recommends government organizations that support CER "allocate research funds to meritorious investigator-initiated proposals that are responsive to priority populations, and create targeted funding opportunities to fill gaps." The health care reform Congress enacted in March requires CER and gives oversight to a federal institute operating in a public/private partnership mode (1"The Tan Sheet" April 19, 2010). The draft notes research does not focus enough on conditions that affect priority populations, and priority populations typically are not recruited for trials. Another problem is the clinical trials infrastructure is not set up to allow for more participation from members of priority groups

Group recommends targeting CER for priority populations

Federal agencies should target comparative effectiveness research funds for studies involving racial and ethnic minorities, children, women, the elderly and people with multiple chronic conditions, the Brookings Institution's Engelberg Center for Health Care Reform says. The center's draft report recommends government organizations that support CER "allocate research funds to meritorious investigator-initiated proposals that are responsive to priority populations, and create targeted funding opportunities to fill gaps." The health care reform Congress enacted in March requires CER and gives oversight to a federal institute operating in a public/private partnership mode (1"The Tan Sheet" April 19, 2010). The draft notes research does not focus enough on conditions that affect priority populations, and priority populations typically are not recruited for trials. Another problem is the clinical trials infrastructure is not set up to allow for more participation from members of priority groups

Related Content

Topics

UsernamePublicRestriction

Register

PS104011

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel